#StudyGraphics: Concomitant chemoradiotherapy improves survival in elderly adults with locally advanced head and neck squamous cell carcinoma
Click to read this study in JAMA Network Open.
Tag: oropharyngeal carcinoma
#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma
Click to read this study in JAMA Otolaryngology - Head & Neck Surgery.
#VisualAbstract: Once-weekly cisplatin is noninferior to cisplatin every 3 weeks for postoperative head and neck cancers
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Taxane monotherapy may be more effective for patients with recurrent or metastatic head and neck cancer and prior nivolumab exposure
Click to read this study in the European Journal of Cancer.
#VisualAbstract: Incidence of HPV-associated oropharyngeal carcinoma expected to increase for older adults between 2020-2045
Click to read this study in JAMA Oncology.
#VisualAbstract: Head and neck cancers are highly prevalent among alcohol consumption-associated malignancies in the global population
Click to read the study in The Lancet Oncology.
#VisualAbstract: Primary surgical treatment is effective for human papillomavirus-negative oropharyngeal carcinoma with T1-2 staging
Click to read this study in Otolaryngology - Head and Neck Surgery.
#VisualAbstract: Induction chemotherapy with docetaxel, cisplatin, and cetuximab offers similar outcomes with a potentially more favorable treatment schedule than 5-fluorouracil
Click to read this study in the European Journal of Cancer.
#VisualAbstract: Pembrolizumab plus cetuximab shows early clinical efficacy for patients with recurrent or metastatic head and neck squamous cell carcinoma
Click to read the study in The Lancet Oncology.
#VisualAbstract: Definitive chemoradiotherapy and surgical treatment are equally effective primary interventions for patients with advanced oroparyngeal squamous cell carcinoma
Click to read the study in JAMA Network Open.